Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,098,431
-$21,015,682 QoQ
Shares Held
2,112,012
-8.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#25
of 712 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $909,020,667 across 5 Drug Manufacturers - General names. SNY ranks #4 (9.9% of the industry book) .
All Filings in SNY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,098,431 | 2,112,012 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $111,114,113 | 2,306,229 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $54,953,402 | 1,164,267 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $30,020,655 | 621,417 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,830,341 | 141,189 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $48,356,941 | 1,002,632 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $160,238,197 | 2,780,465 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,826,735 | 1,418,523 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $433,446 | 8,716 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $71,123,904 | 1,325,949 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $49,998,286 | 927,612 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $29,553,390 | 610,229 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,698,622 | 570,716 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,908,077 | 977,575 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $73,522,165 | 1,432,064 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $53,664,815 | 1,071,154 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||